CSL finally scores $2.3bn rare disease drug deal
SYDNEY: Australian biotech giant CSL has agreed to pay as much as $US1.6 billion ($2.3…
FEATURED
Universities urged to expand short-term elderly care courses
Best affordable seniors housing design for Global Awards shortlisted
Professor thinks shingles vaccine is key to dementia prevention
Traditional house-inspired tiny homes pitched at single downsizers
Senior living operators cater to multiple generations in one community
Candidate proposes converting hospital into assisted living centre
INNOVATION
